Corsair Capital Management - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 55 filers reported holding ENZO BIOCHEM INC in Q2 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.

Quarter-by-quarter ownership
Corsair Capital Management ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q2 2023$87,816
-33.7%
47,726
-12.4%
0.03%
-40.0%
Q1 2023$132,401
+39.0%
54,486
-18.2%
0.05%
+38.9%
Q4 2022$95,239
-43.0%
66,601
-11.3%
0.04%
-51.4%
Q3 2022$167,000
+7.7%
75,049
+0.0%
0.07%
+34.5%
Q2 2022$155,000
-28.9%
75,0260.0%0.06%
+1.9%
Q1 2022$218,000
+16.0%
75,026
+27.9%
0.05%
+54.3%
Q4 2021$188,000
+248.1%
58,657
+246.9%
0.04%
+288.9%
Q2 2021$54,000
-81.6%
16,911
-85.5%
0.01%
-86.8%
Q4 2020$293,000
+597.6%
116,250
+489.2%
0.07%
+353.3%
Q3 2020$42,000
-96.2%
19,729
-80.1%
0.02%
-84.8%
Q2 2017$1,096,000
+135.2%
99,328
+78.4%
0.10%
+23.8%
Q1 2017$466,000
-17.5%
55,691
-31.6%
0.08%
-16.7%
Q4 2016$565,000
+32.9%
81,446
-2.4%
0.10%
+37.1%
Q3 2016$425,000
-22.0%
83,486
-8.6%
0.07%
-15.7%
Q2 2016$545,000
+20.0%
91,293
-8.6%
0.08%
+31.7%
Q1 2016$454,000
-3.8%
99,890
-4.8%
0.06%
+6.8%
Q4 2015$472,000
+26.9%
104,955
-10.4%
0.06%
+51.3%
Q3 2015$372,000
+3.3%
117,195
-1.5%
0.04%
+18.2%
Q2 2015$360,000
+2.0%
118,949
-0.6%
0.03%0.0%
Q1 2015$353,000
-79.1%
119,607
-68.6%
0.03%
-81.6%
Q4 2014$1,692,000
-73.0%
381,059
-68.7%
0.18%
-44.6%
Q3 2014$6,274,000
+77.0%
1,218,208
+80.4%
0.32%
+0.6%
Q2 2014$3,544,000
+32.6%
675,141
+5.1%
0.32%
+18.0%
Q1 2014$2,672,000
+41.5%
642,349
-0.7%
0.27%
+27.7%
Q4 2013$1,889,000
+20.2%
646,943
+3.8%
0.21%
+3.9%
Q3 2013$1,571,000
+38.5%
623,220
+14.3%
0.20%
+41.4%
Q2 2013$1,134,000545,0770.14%
Other shareholders
ENZO BIOCHEM INC shareholders Q2 2022
NameSharesValueWeighting ↓
HARBERT FUND ADVISORS, INC. 5,175,913$7,246,2785.30%
Potomac Capital Management, Inc. 1,455,000$2,037,0002.60%
TANG CAPITAL MANAGEMENT LLC 2,200,000$3,080,0000.44%
RBF Capital, LLC 250,359$350,5030.02%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$36,0000.02%
Shay Capital LLC 62,500$87,5000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 227,100$317,9400.01%
Paradigm Financial Partners, LLC 19,500$26,3250.01%
Shulman DeMeo Asset Management LLC 15,487$21,6820.01%
Renaissance Technologies 2,556,064$3,5780.01%
View complete list of ENZO BIOCHEM INC shareholders